Delivery Order SPE2DB22D9143-SPE2DB25FZB23

Award Date 1/15/25
Potential Completion Date 2/6/25
Potential Value $45K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,916.52 contract is for the provision of Photrexa Cross-Linking Kits, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders...
The U.S. Defense Logistics Agency (DLA) awarded a $26,555.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for PHOTREXA CROSS-LINKING KITS, which are medical devices used in ophthalmic procedures. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,638.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the procurement of 4566383345 - PHOTREXA CROSS-LINKING KIT 6ML, with a period of performance through November 25, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,597.10 contract is for the supply of PHOTREXA CROSS-LINKING KIT 6ML, with an ultimate completion date of August 2, 2024. This delivery order was issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $9,855.93 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of a Photrexa cross-linking kit, a medical product used in eye care procedures. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which covers a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is for the delivery of a specialized pharmaceutical product called PHOTREXA CROSS-LINKING KIT 6ML. The contract, awarded by the Defense Logistics Agency (DLA), is a firm fixed-price delivery order with a ceiling value of $23,235.94 and a performance period through August 8, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,007.42, is to provide the PHOTREXA CROSS-LINKING KIT 6ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,638.84, is for the supply of pharmaceutical products including the Photrexa cross-linking kit. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, with a ceiling value of up...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,277.68, is for the supply of a pharmaceutical product called "PHOTREXA CROSS-LINKING KIT 6ML" to support the recurring medical supply needs of military health facilities. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $6,638.84 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The order is for the PHOTREXA CROSS-LINKING KIT 6ML, with a completion date of March 21, 2024. This delivery order falls under DMS Pharmaceutical Group's existing indefinite delivery contract (IDV) with the DLA, contract 4600082013 under the SPE2DB program, which has a potential value of up to $4,999,999...
  • SPE2DB22D9143
    Indefinite Delivery Contract
  • SPE2DB22D9143-SPE2DB25FZB23
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $44,730.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the "PHOTREXA CROSS-LINKING KIT 6ML" product, with an ultimate completion date of February 6, 2025.

DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare facilities and veterans' medical centers nationwide. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a wide variety of pharmaceutical items.

This specific delivery order contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 4/21/25, 3:42 AM